Perrigo Company plc (PRGO)

Market Cap	3.51B
Revenue (ttm)	4.39B
Net Income (ttm)	-159.60M
Shares Out	136.43M
EPS (ttm)	-1.17
PE Ratio	n/a
Forward PE	8.25
Dividend	$1.10 (4.29%)
Ex-Dividend Date	Nov 29, 2024

Volume	2,112,959
Open	25.67
Previous Close	25.73
Day's Range	25.55 - 26.13
52-Week Range	23.89 - 34.60
Beta	0.52
Analysts	Buy
Price Target	37.00 (+43.69%)
Earnings Date	Nov 6, 2024

About PRGO

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health pr...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Dec 16, 1991
• Employees: 9,140
• Stock Exchange: NYSE
• Ticker Symbol: PRGO
• Website: https://www.perrigo.com

Financial Performance

In 2023, Perrigo Company's revenue was $4.66 billion, an increase of 4.58% compared to the previous year's $4.45 billion. Losses were -$12.70 million, -90.97% less than in 2022.

Analyst Forecast

According to 4 analysts, the average rating for PRGO stock is "Buy." The 12-month stock price forecast is $37.0, which is an increase of 43.69% from the latest price.

Price Target

$37.0

(43.69% upside)

Analyst Consensus: Buy